News
05.03.2019 | Company News
Neurimmune-led research consortium receives Target ALS discovery grant04.03.2019 | Press Release
NovaGo Therapeutics raises CHF 10 million to develop regenerative anti-Nogo therapy for stroke01.03.2019 | Press Release
Neurimmune appoints John Dellapa as General Counsel01.11.2018 | Company News
Neurimmune appoints Natascha Schill as VP Project & Alliance Management18.09.2018 | Press Release
Neurimmune Achieves Milestone in Collaboration with Ono Pharmaceutical12.09.2018 | Company News
Neurimmune appoints Christoph Hock as Chief Medical Officer to lead clinical development04.05.2018 | Company News
Michael Salzmann honored as Corporate Professional of the Year by The M&A Advisor26.04.2018 | Company News
Neurimmune appoints Fabian Buller as Chief Business Officer09.11.2017 | Press Release
Neurimmune Announces Collaboration with Ono Pharmaceutical in Neurodegenerative Diseases Field